Pfizer's GAAP net income for 3 months of 2023 was $5.556 billion, down 29.4% from $7.87 billion in the previous year. Revenue decreased by 28.8% to $18.282 billion from $25.661 billion a year earlier.
Pfizer's GAAP net income for 3 months of 2023 was $5.556 billion, down 29.4% from $7.87 billion in the previous year. Revenue decreased by 28.8% to $18.282 billion from $25.661 billion a year earlier. 
investors.pfizer.com
English (US) 